Anti-Saccharomyces cerevisiae Antibodies Are Only Modestly More Common in Subjects Later Developing Crohn's Disease

BACKGROUND: The pathogenic processes in the preclinical phase of inflammatory bowel disease (IBD) are mainly unknown. AIMS: To study typical antibodies for IBD in the preclinical phase in a cohort of Northern Sweden. METHODS: Antibodies typical for IBD (ASCA, pANCA, lactoferrin-ANCA, antibodies to g...

Descripción completa

Detalles Bibliográficos
Autores principales: Bodecker-Zingmark, L., Widbom, L., Hultdin, J., Eriksson, C., Karling, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9905166/
https://www.ncbi.nlm.nih.gov/pubmed/35989383
http://dx.doi.org/10.1007/s10620-022-07630-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9905166/
https://www.ncbi.nlm.nih.gov/pubmed/35989383
http://dx.doi.org/10.1007/s10620-022-07630-5

Ejemplares similares